Palatin Technologies Inc
F:PTN

Watchlist Manager
Palatin Technologies Inc Logo
Palatin Technologies Inc
F:PTN
Watchlist
Price: 0.066 EUR -52.31% Market Closed
Market Cap: 1.7m EUR

P/OCF
Price to OCF

-0.1
Current
-1.5
Median
19.2
Industry
Higher than median
Lower than industry value

Price to Operating Cash Flow (P/OCF) ratio is a valuation multiple that measures the value of a company’s market capitalization relative to the operating cash flow it generates. Some analysts prefer P/OCF over P/E since earnings can be more easily manipulated than cash flows.

P/OCF
-0.1
=
Market Cap
1.7m EUR
/
Operating Cash Flow
-26.9m USD
Market Cap P/OCF
US
Palatin Technologies Inc
F:PTN
1.7m EUR -0.1
FR
Pharnext SCA
OTC:PNEXF
6T USD -222 137.2
US
Abbvie Inc
NYSE:ABBV
325.9B USD 17.3
US
Amgen Inc
NASDAQ:AMGN
143B USD 11.7
US
Gilead Sciences Inc
NASDAQ:GILD
120.7B USD 11.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
109.2B USD -111.4
US
Epizyme Inc
F:EPE
94.1B EUR -506.4
AU
CSL Ltd
ASX:CSL
115.9B AUD 25.2
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
57.1B USD 14.4
US
Seagen Inc
F:SGT
39.3B EUR -81.7
NL
argenx SE
XBRU:ARGX
30.3B EUR -409.2
 
US
Palatin Technologies Inc
F:PTN
Average P/OCF: 16.1
Negative Multiple: -0.1
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -222 137.2
US
Abbvie Inc
NYSE:ABBV
17.3
US
Amgen Inc
NASDAQ:AMGN
11.7
US
Gilead Sciences Inc
NASDAQ:GILD
11.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -111.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -506.4
AU
CSL Ltd
ASX:CSL
25.2
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
14.4
US
S
Seagen Inc
F:SGT
Negative Multiple: -81.7
NL
argenx SE
XBRU:ARGX
Negative Multiple: -409.2

P/OCF Forward Multiples

Forward P/OCF multiple is a version of the P/OCF ratio that uses forecasted operating cash flow for the P/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/OCF
N/A
2-Years Forward
P/OCF
N/A
3-Years Forward
P/OCF
N/A